Resumen
Introduction Vaccination represents an important strategy to mitigate
COVID-19 related morbidity and mortality by protecting against severe
forms of the disease and reducing hospitalization and death rates. In
this sense, the objective of this study is to estimate the prevalence of
Vaccination Intention (VI) against COVID-19 in Latin America and
Caribbean (LAC). Methods We conducted a systematic review with a
comprehensive search strategy for the following databases: PubMed,
Scopus and Web of Science. A random-effect model meta-analysis was
carried out using observational studies assessing the intention to
vaccines against COVID-19 in LAC countries. The Clopper-Pearson method
was used to estimate 95% Confidence Intervals. The quality assessment
was developed using the Newcastle-Ottawa Scale adapted for
cross-sectional studies. A subgroup analysis by study location and a
sensitivity analysis were developed. Results Nineteen cross-sectional
studies were included. Five meta-analyzes were performed according to
the target population of the included studies. The VI in the general
population of LAC was 78.0% (95%CI: 74.0%–82.0%). The VI for
non-pregnant women was 78.0% (95%CI: 58.0%–99.0%), for elderly
population was 63.0% (95%CI: 59.0%–69.0%), for pregnant women was 69.0%
(95%CI: 61.0%–76.0%) and for health-personnel was 83.0% (95% CI:
71.0%–96.0%). The sensitivity analysis for general population
meta-analysis that included only low risk of bias studies showed a 77.0%
VI (95%CI: 73.0%–82.0%) and for non-pregnant women, 85.0% VI (95%CI:
79.0%–90.0%). Conclusion Despite the high prevalence of VI in general
population found in our study, VI prevalence from elderly people and
pregnant women are lower than other population groups and overall
population.
NOMBRE DE LA REVISTA
Travel Medicine and Infectious Disease
BASE DE DATOS A LA CUAL PERTENECE
Scopus, Pubmed, Web of Science, Embase
TIPO DE MANUSCRITO
Revisión sistemática y meta-análisis
IDIOMA
Inglés
AUTORES DE LA SOCIEDAD
Enrique A. Hernandez-Bustamante
